Skip to content

Laparoscopic sacrocolpopexy versus vaginal sacrospinous fixation for vaginal vault prolapse.

Laparoscopic sacrocolpopexy versus vaginal sacrospinous fixation for vaginal vault prolapse.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21070
Enrollment
74
Registered
2013-04-28
Start date
2013-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse, vault prolapse, laparoscopic sacrocolpopexy, sacrospinous fixation

Interventions

1. Laparoscopic sacrocolpopexy
2. Vaginal sacrospinous fixation.

Sponsors

Máxima Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. Symptomatic vault prolapse POP-Q grade 2 which needs surgical treatment; 2. Eligible for both surgical treatments.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. Previous surgical treatment of vault prolapse; 2. Contra-indication for a surgical intervention; 3. Incapacitated patients.

Design outcomes

Primary

MeasureTime frame
The primary outcome is disease specific quality of life during a follow-up period of one year using the Dutch validated version of the Urinary Distress Inventory (UDI).

Secondary

MeasureTime frame
Secondary outcome will be the effect of the surgical treatment on prolapse related symptoms, post-operative recovery, procedure related morbidity, sexual function, quality of life, anatomical results using the POP-Q classification until one year follow-up, type and number of re-interventions, costs and cost-effectiveness and long term complications.

Contacts

Public ContactA.L.W.M. Coolen

Polikliniek gynaecologie, tav A.Coolen Postbus 7777

a.coolen@mmc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)